title: Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.
abstract: There has been a well documented increase in the use and abuse of prescription opioids and heroin in the United States and other parts of the world. There has also been an increasing focus to increase access to the use of medications (methadone, buprenorphine, Naltrexone/Vivitrol) for opioid addicted individuals under legal supervision. As policymakers engage in strategic initiatives to better prevent and effectively treat chronic opioid addiction, both in the United States and other countries, there are a number of unintended consequences, complicating how best to increase access to effective treatment.
authors.affiliation: a American Association for the Treatment of Opioid Dependence (AATOD), New York , New York , USA.
authors.forename: Mark W
authors.initials: MW
authors.lastname: Parrino
authors.forename: Angelo Giovanni Icro
authors.initials: AG
authors.lastname: Maremmani
authors.forename: Paul N
authors.initials: PN
authors.lastname: Samuels
authors.forename: Icro
authors.initials: I
authors.lastname: Maremmani
mesh_terms: D016739:Behavior, Addictive / Q000188:drug therapy*; D002047:Buprenorphine / Q000627:therapeutic use; D014943:Global Health; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence; D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D058850:Opiate Substitution Treatment / Q000379:methods*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D063487:Prescription Drug Misuse; D014481:United States
chemical_list: D009292:Narcotic Antagonists; D009294:Narcotics; D002047:Buprenorphine; D009271:Naltrexone; D008691:Methadone
keywords: Medication-assisted treatment; heroin addiction; prescription opioid abuse